DIBUCAINE CHOLINESTERASE - ANVISA Registration 80146501806
Access comprehensive regulatory information for DIBUCAINE CHOLINESTERASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501806 and manufactured by SENTINEL CH.SPA. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including SENTINEL CH. SPA, ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80146501806
25351286260201257
56998701000116
Company Information
Dates and Status
Jul 23, 2012
VIGENTE
09/18/2025 19:00:01
DIBUCAINE CHOLINESTERASE
DIBU (Dibucain)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411475
Feb 10, 2020
DIBUCAINE CHOLINESTERASE
Alinity c Dibucaine CHE Reagent Kit
SENTINEL CH. SPA
80146502233
Nov 18, 2019
CHOLINESTERASE
CHED2-CHOLINESTERASE/DIBUCAINE GEN.2
ROCHE DIAGNOSTICS GMBH
10287410741
Jul 14, 2008
CHOLINESTERASE
COLINESTERASE DIALAB
DIALAB GMBH
10300390383
Dec 17, 2018
CHOLINESTERASE
Cholinesterase Elitech
ELITECH CLINICAL SYSTEMS SAS
80171840108
May 16, 2011